Fairfield, NJ (December 18, 2023) – Redi-Data, Inc. announced a multi-year data licensing agreement with a global provider of commercialization services to the life science industry. Their services include analytics, technology, and operational expertise for healthcare and U.S.-based pharmaceutical companies. The company will leverage Redi-Data’s BPA-audited Redi-Physician® product. “We are a national leader in providing the highest quality professional data to the healthcare industry. Our data is relied upon by many of the world’s top life science companies and their service providers,” stated Michael San Inocencio, Director of Sales and Business Development at Redi-Data, Inc. About Redi-Data Redi-Data, Inc. is a leading provider of healthcare professional, consumer, and business postal and email lists. Our recently released digital identity solution, Redi-Data Digital, enables marketers to reach healthcare audiences with precision and scale online. As an official database licensee of several leading professional associations, including the American Medical Association (AMA), Redi-Data provides the most trusted physician information to pharmaceutical brands and their agencies. Clients across various industries use Redi-Data’s high-quality lists, data services, and turn-key marketing solutions to reach their target audience with better data, resulting in better outcomes and affordability. Headquartered in Fairfield, NJ, Redi-Data has sales offices in Berlin, NJ, and Sunrise, FL. Visit www.redidata.com to learn more. Redi-Data Contact Michael San Inocencio msinocencio@redidirect.com Director of Sales and Business Development (973) 227-4380 x4284 Media Contact Mehaique Nawaz PR@stayinfront.com